Prosecution Insights
Last updated: April 19, 2026
Application No. 18/465,450

METHODS FOR ROUTING A GUIDEWIRE FROM A FIRST VESSEL AND THROUGH A SECOND VESSEL IN LOWER EXTREMITY VASCULATURE

Non-Final OA §103
Filed
Sep 12, 2023
Examiner
DEAK, LESLIE R
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Limflow GmbH
OA Round
1 (Non-Final)
75%
Grant Probability
Favorable
1-2
OA Rounds
3y 4m
To Grant
93%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allow Rate
693 granted / 924 resolved
+5.0% vs TC avg
Strong +18% interview lift
Without
With
+18.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
967
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
47.9%
+7.9% vs TC avg
§102
25.1%
-14.9% vs TC avg
§112
11.4%
-28.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 924 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections The numbering of claims is not in accordance with 37 CFR 1.126 which requires the original numbering of the claims to be preserved throughout the prosecution. When claims are canceled, the remaining claims must not be renumbered. When new claims are presented, they must be numbered consecutively beginning with the number next following the highest numbered claims previously presented (whether entered or not). Misnumbered claims 15-21 have been renumbered as 14-20. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 2, 7-10, are rejected under 35 U.S.C. 103 as being unpatentable over WO 2013/163227 to Heuser in view of US 2016/0066993 to Root et al. PNG media_image1.png 530 216 media_image1.png Greyscale [AltContent: textbox (Root)] PNG media_image2.png 446 528 media_image2.png Greyscale [AltContent: textbox (Heuer)] PNG media_image3.png 544 268 media_image3.png Greyscale In the specification and figures, Heuser discloses the apparatus substantially as claimed by Applicant. With regard to claims 2, 6, 7, 12, 17, 18 (renumbered claims 18, 19), Heuser discloses a guidewire routing system comprising a catheter assembly comprising a shaft 70, a capture structure 80 comprising an expandable cage (which suggests a plurality of interconnected struts), and a second catheter with a needle and a guidewire that is configured to advance to the capture structure of the first catheter assembly. The first catheter assembly is configured to capture a guidewire and retract, leading the guidewire from a first vessel to a second vessel (see FIGS 12A-H and accompanying text). Heuser does not disclose a sheath. However, Root discloses a guidewire capture catheter with an expandable funnel 1218 and a sheath 1232 coupled to a hub 550 3in order to capture a guidewire 1204 that has been passed through obstruction 1206, teaching that the sheath in the Root reference functions as claimed by Applicant (see FIGs 11, 12, ¶0034). Where a claimed improvement on a device or apparatus is no more than "the simple substitution of one known element for another or the mere application of a known technique to a piece of prior art ready for improvement," the claim is unpatentable under 35 U.S.C. 103(a). Ex Parte Smith, 83 USPQ.2d 1509, 1518-19 (BPAI, 2007) (citing KSR v. Teleflex, 127 S.Ct. 1727, 1740, 82 USPQ2d 1385, 1396 (2007)). Applicant claims a combination that only unites old elements with no change in the respective functions of those old elements, and the combination of those elements yields predictable results; absent evidence that the modifications necessary to effect the combination of elements is uniquely challenging or difficult for one of ordinary skill in the art, the claim is unpatentable as obvious under 35 U.S.C. 103(a). Ex Parte Smith, 83 USPQ.2d at 1518-19 (BPAI, 2007) (citing KSR, 127 S.Ct. at 1740, 82 USPQ2d at1396. Accordingly, since the applicant[s] have submitted no persuasive evidence that the combination of the above elements is uniquely challenging or difficult for one of ordinary skill in the art, the claim is unpatentable as obvious under 35 U.S.C. 103(a) because it is no more than the predictable use of prior art elements according to their established functions resulting in the simple substitution of one known element for another or the mere application of a known technique to a piece of prior art ready for improvement. In the instant case, it would have been obvious to a person of ordinary skill in the art to use the sheath system disclosed by Root on the catheter system disclosed by Heuser, since each embodiment is known in the art. With regard to claims 3-5, 13-16 (renumbered claims 15-17), Heuser discloses that part of the stent graft comprises nitinol, and that the guidewire assembly may comprise a radiopaque marker (see ¶0017, 0051). It would have been obvious to one having ordinary skill in the art at the time the invention was made to use nitinol and radiopaque markers as disclosed by Heuser in the combination suggested by the prior art, since it has been held to be within the general skill of a worker in the art to select a known material on the basis of its suitability for the intended use as a matter of obvious design choice. See MPEP § 2144.07. With regard to claims 8-10 and 19 (renumbered claim 20), Heuser discloses that the first blood vessel with the capture structure is a femoral vein, and the second blood vessel with the occlusion is a femoral artery. With regard to claims 11 and 20 (renumbered claim 21), both references disclose a hub (Heuser ¶0052 y-shaped hub with multiple ports 72; Root ¶0034 hub with multiple ports 550), demonstrating that hubs are well-known elements in the art of vascular catheterization. The instant recitation of a hub does not patentably distinguish the claims from the cited prior art. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: US 6,379,319 Garibotto et al Snaring guidewires to bypass an occlusion. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LESLIE R DEAK whose telephone number is (571)272-4943. The examiner can normally be reached Monday-Friday, 9am to 5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at 571-272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LESLIE R DEAK/ Primary Examiner, Art Unit 379 9 January 2026
Read full office action

Prosecution Timeline

Sep 12, 2023
Application Filed
Jan 09, 2026
Non-Final Rejection — §103
Apr 16, 2026
Examiner Interview Summary
Apr 16, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599497
IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME
2y 5m to grant Granted Apr 14, 2026
Patent 12594186
AQUEOUS HUMOR DRAINAGE DEVICE WITH ADJUSTABLE TUBE DIAMETER
2y 5m to grant Granted Apr 07, 2026
Patent 12575972
GLAUCOMA STENT AND METHODS THEREOF FOR GLAUCOMA TREATMENT
2y 5m to grant Granted Mar 17, 2026
Patent 12569604
METHOD AND DEVICES FOR DETERMINING A TIME POINT FOR MEASURING PRESSURE MEASUREMENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12569654
SYSTEMS AND METHODS FOR TREATMENT OF FLUID OVERLOAD
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
75%
Grant Probability
93%
With Interview (+18.0%)
3y 4m
Median Time to Grant
Low
PTA Risk
Based on 924 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month